Ho, Anthony
Ho, Anthony Dick 1948-
Anthony Ho
Ho, Anthony D.
Ho, Anthony, 1948-
VIAF ID: 35005199 (Personal)
Permalink: http://viaf.org/viaf/35005199
Preferred Forms
- 100 0 _ ‡a Anthony Ho
- 100 0 _ ‡a Anthony Ho
- 100 1 _ ‡a Ho, Anthony
-
-
-
- 100 1 _ ‡a Ho, Anthony
-
- 100 1 _ ‡a Ho, Anthony D.
-
- 100 1 _ ‡a Ho, Anthony Dick ‡d 1948-
-
4xx's: Alternate Name Forms (16)
5xx's: Related Names (3)
- 510 2 _ ‡a Heidelberg, Univ
- 510 2 _ ‡a Medizinische Universitäts-Poliklinik ‡g Heidelberg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Medizinische Universitäts-Poliklinik
Works
Title | Sources |
---|---|
Aging and replicative senescence have related effects on human stem and progenitor cells | |
Altern: Biologie und Chancen Alter und Altern individuell, kollektiv und die Folgen | |
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis. | |
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement | |
CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantation. | |
Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline | |
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 | |
Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor. | |
Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse. | |
The coming economic flood | |
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients. | |
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia | |
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients. | |
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-Immunotherapy. | |
DNA methylation changes during long-term in vitro cell culture are caused by epigenetic drift | |
Drug-perturbation-based stratification of blood cancer | |
Dynamic cellular phynotyping defines specific mobilization mechanisms of human hematopoietic stem and progenitor cells induced by SDF1α versus synthetic agents. | |
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma. | |
Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia | |
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis | |
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis | |
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial. | |
Frequent mechanical stress suppresses proliferation of mesenchymal stem cells from human bone marrow without loss of multipotency | |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening | |
Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone | |
Glucocorticoid-Rezeptoren und terminale Desoxynucleotidyl-Transferase als Klassifizierungsmerkmale und prognostische Faktoren bei Leukämien und malignen Lymphomen | |
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapy. | |
Human haematopoietic stem cell lineage commitment is a continuous process | |
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14). | |
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV | |
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis | |
Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis | |
Inductor based ESD protection schemes for LNAs. | |
Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells | |
Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. | |
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells | |
Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis. | |
Mesenchymal stem cells are resistant to carbon ion radiotherapy. | |
Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin. | |
Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1 | |
miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression | |
"Nicht blos künstlich in einem Spitale" zweihundert Jahre Medizinische Universitäts-Poliklinik Heidelberg und ihr Weg von der Stadtpraxis bis zur Blutstammzelltransplantation | |
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses | |
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial | |
Potential therapeutic targets in plasma cell disorders: A flow cytometry study. | |
Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1. | |
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantation | |
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study | |
Protein abundance of AKT and ERK pathway components governs cell type‐specific regulation of proliferation | |
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients | |
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla | |
Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia | |
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions | |
Shear stress regulates adhesion and rolling of CD44+ leukemic and hematopoietic progenitor cells on hyaluronan. | |
Simple Physical Model Unravels Influences of Chemokine on Shape Deformation and Migration of Human Hematopoietic Stem Cells | |
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial | |
Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis | |
Specific Age-Associated DNA Methylation Changes in Human Dermal Fibroblasts | |
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis | |
Stem cell transplantation biology, processing, and therapy | |
The Stromal Activity of Mesenchymal Stromal Cells | |
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation. | |
Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis. | |
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens. | |
Untersuchungen über die Existenz gewebsspezifischer wachstumsregulierender Hemmsubstanzen (Chalone) in der Leber | |
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin. |